1 study found for:    NCT01533948
Show Display Options
Rank Status Study
1 Recruiting Axitinib in Treating Patients With Melanoma That is Metastatic or Cannot Be Removed by Surgery
Conditions: Extraocular Extension Melanoma;   Metastatic Intraocular Melanoma;   Recurrent Intraocular Melanoma;   Recurrent Melanoma;   Stage IIIA Intraocular Melanoma;   Stage IIIA Melanoma;   Stage IIIB Intraocular Melanoma;   Stage IIIB Melanoma;   Stage IIIC Intraocular Melanoma;   Stage IIIC Melanoma;   Stage IV Intraocular Melanoma;   Stage IV Melanoma
Interventions: Drug: axitinib;   Other: laboratory biomarker analysis

Indicates status has not been verified in more than two years